LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 PF431396
1.11
uM
LJP5
 0.4135 0.0161 0.0253 0.0338
SK-BR-3 PF477736
1.11
uM
LJP5
 0.3183 0.0327 -0.1380 0.0999
SK-BR-3 PF562271
1.11
uM
LJP6
 0.5013 0.0224 0.1728 0.0223
SK-BR-3 PHA-665752
1.11
uM
LJP5
 1.0645 0.0376 1.1062 0.0629
SK-BR-3 PHA-793887
1.11
uM
LJP6
 0.3799 0.0284 -0.0294 0.0385
SK-BR-3 PI103
1.11
uM
LJP6
 0.3941 0.0315 -0.0094 0.0772
SK-BR-3 PLX-4720
1.11
uM
LJP5
 1.0555 0.0301 1.0979 0.0532
SK-BR-3 QL-X-138
1.11
uM
LJP6
 0.4835 0.0172 0.1408 0.0440
SK-BR-3 QL-XII-47
1.11
uM
LJP6
 0.3428 0.0140 -0.0960 0.0711
SK-BR-3 Radicicol
1.11
uM
LJP5
 0.4076 0.0266 0.0113 0.0830
SK-BR-3 Radicicol
1.11
uM
LJP6
 0.3768 0.0251 -0.0392 0.0791
SK-BR-3 Seliciclib
1.11
uM
LJP5
 0.9164 0.0253 0.8649 0.0375
SK-BR-3 Ruxolitinib
1.11
uM
LJP5
 0.9646 0.0105 0.9392 0.0214
SK-BR-3 XL147
1.11
uM
LJP5
 1.1502 0.0432 1.2445 0.0668
SK-BR-3 Saracatinib
1.11
uM
LJP6
 0.9323 0.0298 0.8816 0.0548
SK-BR-3 Selumetinib
1.11
uM
LJP6
 0.9904 0.0192 0.9857 0.0302
SK-BR-3 Sirolimus
1.11
uM
LJP6
 0.6158 0.0105 0.3598 0.0388
SK-BR-3 Sorafenib
1.11
uM
LJP6
 0.9932 0.0185 0.9919 0.0316
SK-BR-3 SU11274
1.11
uM
LJP5
 1.0152 0.0306 1.0298 0.0491
SK-BR-3 Fedratinib
1.11
uM
LJP5
 0.8567 0.0375 0.7678 0.0534
SK-BR-3 TGX221
1.11
uM
LJP5
 0.9934 0.0182 0.9918 0.0316
SK-BR-3 Torin1
1.11
uM
LJP6
 0.3416 0.0182 -0.1005 0.0932
SK-BR-3 Torin2
1.11
uM
LJP5
 0.3084 0.0229 -0.1524 0.0765
SK-BR-3 Tozasertib
1.11
uM
LJP5
 0.3525 0.0050 -0.0783 0.0555
SK-BR-3 Trametinib
1.11
uM
LJP5
 0.7653 0.0238 0.6064 0.0526